{"id":"W2300659078","doi":"10.1200/jco.2013.31.4_suppl.lba5","title":"REGARD: A phase III, randomized, double-blinded trial of ramucirumab and best supportive care (BSC) versus placebo and BSC in the treatment of metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and/or fluoropyrimidine-containing combination therapy.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Ramucirumab; Medicine; Internal medicine; Clinical endpoint; Hazard ratio; Progression-free survival; Gastroenterology; Placebo; Cancer; Oncology; Phases of clinical research; Randomized controlled trial; Toxicity; Chemotherapy; Pathology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002560908,0.002890822,0.003053947,0.0005747374,0.0006749784,0.001335103,0.001308184,0.002767479,0.008757082],"category_scores_gemma":[0.002139229,0.0009955917,0.001650037,0.0004038837,0.001887535,0.001445721,0.0005135253,0.004031624,0.001627567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008543615,"about_ca_system_score_gemma":0.001599931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007006137,"about_ca_topic_score_gemma":0.001990086,"domain_scores_codex":[0.9992321,0.0004597497,0.00004021906,0.0001218543,0.00004674546,0.00009940186],"domain_scores_gemma":[0.9990675,0.0002118081,0.0002168958,0.00007701192,0.00005472214,0.0003721669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859052,0.005851553,0.0002249303,0.0002870889,0.0001927422,0.00002679757,0.00003445427,0.0001256487,0.002133898,0.0000829666,0.0004973563,0.004637373],"study_design_scores_gemma":[0.9560408,0.04286461,0.0003209174,0.00001283472,0.0001008096,0.00001540742,0.000008151112,0.0001158031,0.000179105,0.00006766237,0.000268708,0.000005071998],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9724416,0.00437154,0.001171446,0.001404272,0.001211005,0.01248369,0.002353556,0.0003892102,0.004173621],"genre_scores_gemma":[0.9706255,0.002508256,0.00260988,0.00205547,0.0009985215,0.01361232,0.001729475,0.00004818949,0.005812272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008757082,"threshold_uncertainty_score":0.02929538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1596108721350184,"score_gpt":0.4579740626354947,"score_spread":0.2983631905004763,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}